ITGB8 and hepatocellular carcinoma: Hou W et al. (Hou et al., 2022) chose two LVN resistant HCC cell lines and consequently screened integrin subunit beta 8 (ITGB8) as a critical contributor to LVN acquired drug resistance in HCC cell lines.